The new SPAC intends to focus on businesses that have their primary operations located in North America and Europe in the neuro-musculoskeletal industry. Viscogliosi is led by Chief Executive Officer, President and Chairman John J. Viscogliosi, and Treasurer and Chief Financial Officer Steve Ward.
Total SPAC deal count for 2022 year-to-date is now 4. This offering is expected to close on Tuesday, January 11.
Raymond James & Associates, Inc. acted as sole book-running manager for the offering. Loeb & Loeb LLP is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.